treatment guidelines

Research in Review

High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival

04/29/2016

JCP Editors

Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...

...

04/29/2016

Journal of Clinical Pathways

Research in Review

Wide Variability in Radiation Therapy Following Neoadjuvant Chemotherapy for Patients With Breast Cancer

04/08/2016

JCP Editors

A study conducted by members of the American College of Surgeons has identified a need for greater uniformity and guidelines regarding radiation therapy following neoadjuvant chemotherapy in patients with initial...

A...

04/08/2016

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways

NCCN Announces Changes to Guidelines for NSCLC

04/06/2016

JCP Editors

New guidelines for non-small cell lung cancer (NSCLC) recommend testing for epidermal growth factor receptor (EGRF) mutations as a part of routine care for patients diagnosed with non-small cell lung cancer (NSCLC),...

New...

04/06/2016

Journal of Clinical Pathways

Major Changes to NCCN Guidelines for Multiple Myeloma Announced

04/05/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) has announced three major changes to its guidelines for the treatment of multiple myeloma (MM) that broaden the population of patients eligible to start therapy,...

The...

04/05/2016

Journal of Clinical Pathways

NCCN CEO Compares Evidence Blocks With Other Tools to Assess Value of Cancer Care Treatments

04/01/2016

JCP Editors

In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...

In a...

04/01/2016

Journal of Clinical Pathways

ASCO Endorses EAU Guidelines for Muscle-Invasive, Metastatic Bladder Cancer

03/24/2016

JCP Editors

The American Society of Clinical Oncology (ASCO) has endorsed guidelines established by the European Association of Urology (EAU) for the treatment of muscle-invasive bladder cancer (MIBC) and metastatic bladder...

The...

03/24/2016

Journal of Clinical Pathways

Quality Metrics Not Linked to Improved Survival for Patients With Colon Cancer

03/10/2016

JCP Editors

Results from a study presented at the Society for Surgical Oncology Annual Cancer Symposium (March 2-5; Boston, MA) suggest that adhering to National Quality Forum (NQF) colon cancer quality metrics may not correlate...

...

03/10/2016

Journal of Clinical Pathways

Research in Review

Patients and Physicians Develop Similar Guidelines for Rheumatoid Arthritis

01/26/2016

JCP Editors

Guidelines for rheumatoid arthritis (RA) formulated by a panel of patients had most of the same recommendations as those developed by a panel of physicians, researchers report. Clinical practice guidelines (CPGs)...

...

01/26/2016

Journal of Clinical Pathways

Adolescent Hodgkin Lymphoma Patients Not Receiving Optimal Follow-up Care

01/18/2016

JCP Editors

Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...

...

01/18/2016

Journal of Clinical Pathways